Q2 2026 13F · SEC CIK 1966116
Cravens & Co Advisors, LLC
Wealth managerFiled 2026-08-12 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $149.0M
- Reported positions
- 67
- Top holdings a year, 3 yrs
- +13.2%
- Assets under management
- $311.1M
Cravens & Co Advisors, LLC is a wealth manager that reported 67 positions worth $149.0M in its Q2 2026 13F, filed 2026-08-12. Its largest holdings were Dimensional U.s. Core Equity 2 (DFAC, 10.5%), Dimensional (DFEM, 8.6%), Smartfinancial Inc (SMBK, 6.9%). A portfolio copying its top holdings returned 13.2% a year over the last 3 years, against 20.4% for the S&P 500.
Cravens & Co Advisors, LLC holdings largest 50 of 67 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Cravens & Co Advisors, LLC bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
- MSFT Microsoft Corp+18.6% shares
- META Meta Platforms Inc Class A+13.7% shares
Reduced
- SBUX Starbucks Corp Com-57.2% shares
- RTX Rtx Corporation Com-55.0% shares
- ILMN Illumina Inc-28.8% shares
- AFRM Affirm Hldgs Inc-27.2% shares
- NET Cloudflare Inc-26.8% shares
- TFLO Ishares Tr-23.6% shares
- PULS Pgim Ultra Short Bond ETF-21.1% shares
- CVX Chevron Corp New-20.9% shares
Left the top 50
- EOG Eog Res Incwas 0.7%
- ABT Abbott Laboratorieswas 0.6%
- SHOP Shopify Incwas 0.4%
- TOST Toast Incwas 0.3%
- CNQ Canadian Nat Res Ltd Med Term Comwas 0.3%
- GSK Gsk PLCwas 0.3%
- TRP Tc Energy Corpwas 0.3%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +13.2% /yr
- S&P 500 +20.1%
- 3 years
- +13.2% /yr
- S&P 500 +20.4%
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $149.0M | 67 |
| Q1 2026 | $153.9M | 64 |
| Q4 2025 | $152.7M | 63 |
| Q3 2025 | $146.5M | 58 |
| Q2 2025 | $134.0M | 55 |
| Q1 2025 | $128.7M | 57 |
| Q4 2024 | $131.3M | 62 |
| Q3 2024 | $129.5M | 60 |
| Q2 2024 | $134.7M | 70 |
| Q1 2024 | $120.4M | 72 |
| Q4 2023 | $115.9M | 71 |
| Q3 2023 | $106.4M | 70 |
Questions about Cravens & Co Advisors, LLC's portfolio
What stocks does Cravens & Co Advisors, LLC own?
Cravens & Co Advisors, LLC's latest 13F, for Q2 2026 and filed Aug 12, 2026, lists 67 positions worth $149.0M. The largest are Dimensional U.s. Core Equity 2 (DFAC) at 10.5%, Dimensional (DFEM) at 8.6%, Smartfinancial Inc (SMBK) at 6.9%, Dfa Dimensional Intl Core Equit (DFIC) at 6.5% and Vmbs (VMBS) at 5.9%.
What did Cravens & Co Advisors, LLC buy last quarter?
In Q2 2026, Cravens & Co Advisors, LLC added Microsoft Corp (MSFT) (+18.6% shares) and Meta Platforms Inc Class A (META) (+13.7% shares), compared with its Q1 2026 filing.
What did Cravens & Co Advisors, LLC sell last quarter?
In Q2 2026, Cravens & Co Advisors, LLC cut from its top 50 Eog Res Inc (EOG), cut from its top 50 Abbott Laboratories (ABT), cut from its top 50 Shopify Inc (SHOP), cut from its top 50 Toast Inc (TOST), cut from its top 50 Canadian Nat Res Ltd Med Term Com (CNQ), Starbucks Corp Com (SBUX) (-57.2% shares), Rtx Corporation Com (RTX) (-55.0% shares) and Illumina Inc (ILMN) (-28.8% shares), compared with its Q1 2026 filing.
How has Cravens & Co Advisors, LLC's portfolio performed?
A portfolio copying Cravens & Co Advisors, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +13.2% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +13.2% against +20.1%.
When is Cravens & Co Advisors, LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Cravens & Co Advisors, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Cravens & Co Advisors, LLC manage?
Cravens & Co Advisors, LLC reported $311.1M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $149.0M.